241 related articles for article (PubMed ID: 15782133)
21. The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of alphavbeta3 and alphavbeta5.
Crockett JC; Schütze N; Tosh D; Jatzke S; Duthie A; Jakob F; Rogers MJ
Endocrinology; 2007 Dec; 148(12):5761-8. PubMed ID: 17823253
[TBL] [Abstract][Full Text] [Related]
22. Expression and regulation of Cyr61 in human breast cancer cell lines.
Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
[TBL] [Abstract][Full Text] [Related]
23. alpha(v) integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells.
Cruet-Hennequart S; Maubant S; Luis J; Gauduchon P; Staedel C; Dedhar S
Oncogene; 2003 Mar; 22(11):1688-702. PubMed ID: 12642872
[TBL] [Abstract][Full Text] [Related]
24. Signaling molecules implicated in heregulin induction of growth arrest and apoptosis.
Guerra-Vladusic FK; Vladusic EA; Tsai MS; Lupu R
Oncol Rep; 2001; 8(6):1203-14. PubMed ID: 11605034
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D
Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489
[TBL] [Abstract][Full Text] [Related]
26. Herstatin inhibits heregulin-mediated breast cancer cell growth and overcomes tamoxifen resistance in breast cancer cells that overexpress HER-2.
Jhabvala-Romero F; Evans A; Guo S; Denton M; Clinton GM
Oncogene; 2003 Nov; 22(50):8178-86. PubMed ID: 14603258
[TBL] [Abstract][Full Text] [Related]
27. Grb2 downregulation leads to Akt inactivation in heregulin-stimulated and ErbB2-overexpressing breast cancer cells.
Lim SJ; Lopez-Berestein G; Hung MC; Lupu R; Tari AM
Oncogene; 2000 Dec; 19(54):6271-6. PubMed ID: 11175341
[TBL] [Abstract][Full Text] [Related]
28. Akt-dependent T198 phosphorylation of cyclin-dependent kinase inhibitor p27kip1 in breast cancer.
Motti ML; De Marco C; Califano D; Fusco A; Viglietto G
Cell Cycle; 2004 Aug; 3(8):1074-80. PubMed ID: 15280662
[TBL] [Abstract][Full Text] [Related]
29. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.
Yang C; Klein EA; Assoian RK; Kazanietz MG
Biochem J; 2008 Feb; 410(1):167-75. PubMed ID: 17941827
[TBL] [Abstract][Full Text] [Related]
30. Tiam1 overexpression potentiates heregulin-induced lymphoid enhancer factor-1/beta -catenin nuclear signaling in breast cancer cells by modulating the intercellular stability.
Adam L; Vadlamudi RK; McCrea P; Kumar R
J Biol Chem; 2001 Jul; 276(30):28443-50. PubMed ID: 11328805
[TBL] [Abstract][Full Text] [Related]
31. CYR61 regulates BMP-2-dependent osteoblast differentiation through the {alpha}v{beta}3 integrin/integrin-linked kinase/ERK pathway.
Su JL; Chiou J; Tang CH; Zhao M; Tsai CH; Chen PS; Chang YW; Chien MH; Peng CY; Hsiao M; Kuo ML; Yen ML
J Biol Chem; 2010 Oct; 285(41):31325-36. PubMed ID: 20675382
[TBL] [Abstract][Full Text] [Related]
32. Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway.
Lin MT; Zuon CY; Chang CC; Chen ST; Chen CP; Lin BR; Wang MY; Jeng YM; Chang KJ; Lee PH; Chen WJ; Kuo ML
Clin Cancer Res; 2005 Aug; 11(16):5809-20. PubMed ID: 16115920
[TBL] [Abstract][Full Text] [Related]
33. CYR61 stimulates human skin fibroblast migration through Integrin alpha vbeta 5 and enhances mitogenesis through integrin alpha vbeta 3, independent of its carboxyl-terminal domain.
Grzeszkiewicz TM; Kirschling DJ; Chen N; Lau LF
J Biol Chem; 2001 Jun; 276(24):21943-50. PubMed ID: 11287419
[TBL] [Abstract][Full Text] [Related]
34. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
35. Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin alpha 6beta 1 and cell surface heparan sulfate proteoglycans.
Chen N; Chen CC; Lau LF
J Biol Chem; 2000 Aug; 275(32):24953-61. PubMed ID: 10821835
[TBL] [Abstract][Full Text] [Related]
36. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
[TBL] [Abstract][Full Text] [Related]
37. Heregulin regulates the actin cytoskeleton and promotes invasive properties in breast cancer cell lines.
Hijazi MM; Thompson EW; Tang C; Coopman P; Torri JA; Yang D; Mueller SC; Lupu R
Int J Oncol; 2000 Oct; 17(4):629-41. PubMed ID: 10995872
[TBL] [Abstract][Full Text] [Related]
38. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
39. Heregulin-beta1 regulates the estrogen receptor-alpha gene expression and activity via the ErbB2/PI 3-K/Akt pathway.
Stoica GE; Franke TF; Wellstein A; Morgan E; Czubayko F; List HJ; Reiter R; Martin MB; Stoica A
Oncogene; 2003 Apr; 22(14):2073-87. PubMed ID: 12687010
[TBL] [Abstract][Full Text] [Related]
40. CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway.
Chen PS; Wang MY; Wu SN; Su JL; Hong CC; Chuang SE; Chen MW; Hua KT; Wu YL; Cha ST; Babu MS; Chen CN; Lee PH; Chang KJ; Kuo ML
J Cell Sci; 2007 Jun; 120(Pt 12):2053-65. PubMed ID: 17550972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
